What podcasts say about Novo Nordisk
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Novo Nordisk
9 statements · 3 positive · 6 negative
Novo Nordisk disappointed investors with its turnaround plans.
“Novo Nordisk. Disappointing investors here.”
Open the episode · Novo Slides; Accenture Up; Arhaus UpgradeListen at 2:22
Novo Nordisk quickly lost its GLP-1 market lead to Eli Lilly.
“it quickly lost its lead. to Eli Lilly.”
Open the episode · Novo Slides; Accenture Up; Arhaus UpgradeListen at 2:31
Loss of exclusivity will challenge Novo Nordisk
“this loss of exclusivity on some of those drugs is going to be a huge challenge for Novo Nordisk”
Open the episode · Novo Nordisk Drops, Puma Down, Trainline RisesListen at 1:12
Novo Nordisk lost obesity-drug leadership to Eli Lilly
“They lost their leadership in the obesity drug race to Eli Lilly.”
Open the episode · Novo Nordisk Drops, Berkeley FallsListen at 1:14
Novo Nordisk needs a new growth source because its shares have lagged since 2024.
“the company really needs a new source of growth because shares have been lagging badly since that peak in 2024”
Open the episode · Apple Tumbles, Amazon Soars, Novo Nordisk Slides as New Drug Fails in Closely Watched Heart, Stroke Study On this episode of Stock Movers:Listen at 3:30
Novo Nordisk stock is reacting positively to the foundation initiative.
“Novo is, is reacting to that positively this morning.”
Open the episode · ASML Dips, Novo Jumps, Vestas GainsListen at 3:44
Novo Nordisk’s obesity-care unit is growing at its slowest rate since 2020.
“it's the slowest for that unit since 2020.”
Open the episode · SpaceX Agrees to Merge With Cursor; Novo to File for China Approval of Wegovy; Dave & Buster's Misses EstimatesListen at 2:55
Novo Nordisk’s foundation structure has protected its scientific-integrity ethos for over a century.
“this structure has endured and protected the ethos of scientific integrity of Novo Nordisk for more than 100 years.”
Open the episode · How to build a company that withstands any era | Eric Ries, Lean Startup authorListen at 23:49
Novo Nordisk’s foundation intervention ultimately created over $500 billion in shareholder value.
“Their intervention ultimately created more than $500 billion of shareholder value.”
Open the episode · How to build a company that withstands any era | Eric Ries, Lean Startup authorListen at 25:05
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.